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Abstract:  Autophagy is an evolutionarily conserved cellular degradation pathway 
involving the digestion of intracellular components via the lysosomal pathway. The 
autophagic pathway constitutively maintains cellular homeostasis by recycling cytoplasmic 
organelles and proteins, but it is also stimulated by environmental stress conditions, such 
as starvation, oxidative stress, and the accumulation of misfolded proteins. It also acts as a 
cellular defense mechanism against microorganisms by contributing to both the innate and 
adaptive immunity, and by eliminating intracellular pathogens (xenophagy). There is 
growing evidence that host cells try to control Herpesvirus infections by activating the 
autophagic machinery. However, it is well-known that Herpesviruses are smart pathogens 
and several, such as HSV-1, HCMV and HHV-8, are known to have developed numerous 
defense strategies for evading the host’s immune response. Inhibition of the antiviral 
autophagic mechanism has also been reported. Autophagy has also been shown to enhance 
the major histocompatibility complex presentation of at least two viral proteins, the EBV-
encoded EBNA-1 and the HSV-1 encoded gB. In this review, we present an overview of 
recent advances in our understanding of the complex interplay between autophagy and 
Herpesviruses. 
Keywords:  autophagy; Herpesvirus; HSV-1; cytomegalovirus; HHV-8; immunity; 
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1. Overview of Autophagy 
Macroautophagy (referred to as “autophagy” below) involves the formation of a double membrane-
bound vacuole, known as an autophagosome, which ultimately fuses with the lysosomal compartment 
to degrade the sequestered material [1]. Under normal conditions, basal autophagy has a housekeeping 
function, allowing cells to recycle organelles and long-lived proteins, but autophagy is also induced in 
response to various forms of stress, such as starvation, depletion of growth factors, low energy levels, 
hypoxia, oxidative stress, ER stress and pathogen infection. Under these conditions, the upregulation 
of autophagy enables the cell to survive by providing amino acids and energy, by clearing damaged 
proteins and organelles, and by eliminating intracellular pathogenic microbes via a process known as 
xenophagy. Autophagy has also recently been shown to be involved in diverse aspects of the innate 
and adaptative immune response (reviewed in [2]). 
1.1. Autophagosome Formation and Expansion 
During autophagy, part of the cytoplasm is engulfed by a double membrane (the isolation 
membrane), which first elongates and then closes to form the autophagosome (Figure 1). 
Autophagosomes use dynein motors to travel along the microtubule network towards the microtubule-
organizing center, where they merge with endosomes (to form amphisomes) or with lysosomes (to 
form autolysosomes). Next, the inner autophagosomal membrane and the sequestered material are 
degraded by lysosomal hydrolases. The origin of the autophagosomal membrane is still uncertain, but 
there is growing evidence that the Endoplasmic Reticulum (ER) provides lipids for growing 
autophagosomes [3,4]. So far, more than 30 AuTophaGy-related (Atg) genes have been identified in 
yeast, and most of them are conserved in eukaryotes [5]. The formation of autophagosomes involves 
18 different Atg genes. 
The nucleation and assembly of the initial phagophore membrane is a highly regulated process 
mediated by two complexes. (i) A stable complex formed by ULK1/2, Atg13, FIP200 and a novel 
Atg13-binding protein, known as Atg101, which localizes to the phagophore during starvation in 
mammalian cells [6,7]. This complex mediates mTOR (mammalian Target of Rapamycin) kinase-
signaling to the autophagic machinery [8,9]. Its counterpart in yeast, the Atg1-Atg13-Atg17 complex, 
is also essential for the regulation of autophagy, and integrates regulation from TOR and diverse 
signaling pathways [10–12]. (ii) The Beclin 1:hVps34 macromolecular complex is required for the 
nucleation, and assembly of the initial phagophore membrane (Figure 1). This complex consists of the 
class III phosphatidylinositol 3-kinase (PI3K) (or hVps34), its regulatory protein kinase p150 or 
hVps15, Beclin 1 (Atg6 in yeast), and Atg14L (or Barkor and Atg14 in yeast) [13,14]. 
This complex, and other Atg proteins, recruit the Atg5-Atg12-Atg16L multimeric complex, and the 
lipidated form of LC3 (microtubule-associated protein light chain 3), known as Atg8 in yeast, to the 
phagophore, resulting in membrane elongation. These last two components result from two 
sequentially acting ubiquitin-like conjugation systems (Figure 1). In the first conjugation system, 
Atg12 is activated by the E1-like enzyme, Atg7, and conjugated to Atg5 by the E2-like enzyme, 
Atg10. Atg12-Atg5 binds non-covalently to Atg16L, to form the Atg16L-Atg12-Atg5 complex which 
associates with the membrane [15–18].  
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Figure 1. The autophagic machinery and its regulation pathways. 
 
Autophagosome formation is controlled by the ULKs-FIP200-Atg13 complex (1) and the Beclin 
1:hVps34:Atg14L complex (2). Expansion and closure of the autophagosomal membrane are 
dependent on the Atg5-Atg12-Atg16L complex (3) and on the mammalian homolog of Atg8, LC3 
(4). Two ubiquitin-like conjugation systems (5) lead to the conjugation of Atg12 to Atg5, and of 
LC3 to phosphatidylethanolamine (PE). The Atg5-Atg12 conjugate associated with Atg16 
contributes to the stimulation of LC3 conjugation. Some important signaling pathways involved in 
the regulation of autophagy are presented here. (A) Beclin 1 is a platform protein that can interact 
with a variety of cellular proteins. Positive regulators of Beclin 1 are boxed in green. The 
interaction of Beclin 1 with anti-apoptotic proteins of the Bcl-2 family blocks the induction of 
autophagy. (B) In the presence of amino acids, insulin, growth factors and energy, mTOR represses 
autophagy by inhibiting the kinase activity of ULKs. In contrast, in the absence of amino acids, 
growth factors and/or activation of the AMPK, mTOR is inhibited and autophagy initiated by the 
ULKs-FIP200-Atg13 complex. (C) The kinase PKR, activated by viral infections via double 
stranded RNA (dsRNA) and IFN, leads to the phosphorylation of eIF2. Phosphorylated eIF2 
allows host shutoff of the protein synthesis, and the induction of apoptosis and stimulation of 
autophagy to occur. Some autophagy proteins are targeted by Herpesvirus-encoded proteins. 
ICP34.5 (HSV-1), vBcl-2 (HHV8) and M11 (MH68) inhibits autophagy by interacting with 
Beclin 1. In order to block autophagy, ICP34.5 is also able to recruit the phosphatase 1 alpha 
PP1leading to the dephosphorylation of eIF2. Us11 (HSV-1) blocks PKR directly in the late 
stages of infection. vFLIP (HHV8, MH68) inhibits autophagy by interacting with Atg3. HCMV 
may inhibit autophagy via mTOR activation. Viruses 2010, 2                                       
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The second conjugation system involves the Atg7 (E1-like) and Atg3 (E2-like) proteins that 
mediate the conjugation of LC3 (previously processed by Atg4) to phosphatidylethanolamine (PE) [19]. 
Opposite to the unconjugated cytosolic LC3 form I, the lipidated form of LC3 (also known as LC3 
form II) is associated with the autophagosomal membranes [20]. The conjugation of LC3 (detected by 
Western blot analysis), and the membrane localization of lipidated LC3 (detected by fluorescent 
microscopy) are the usual markers of early autophagy [21]. Readers interested in methods used for 
monitoring autophagy can consult a comprehensive review on this topic [21]. 
It has been shown recently that the Beclin 1:hVps34:p150 core complex is in fact involved in the 
various stages of autophagy, and the specificity of the complex is conferred by binding to Atg14L, to 
UVRAG, or to UVRAG and Rubicon [13]. Atg14L recruits the complex to the autophagosomal 
membrane, and is necessary for autophagosome formation, whereas the Beclin 1:hVps34:p150 
complex formed with UVRAG is involved in autophagosome and endosome maturation. In contrast, 
when UVRAG is combined with Rubicon, it prevents the maturation of autophagosomes and 
endosomes [22]. 
1.2. Regulation of Autophagy 
The mTOR kinase is essential for the control of autophagy by growth factors, insulin, nutrients, 
calcium signaling, ATP level, hypoxia and oxidative stress [23]. This key inhibitor of autophagy is 
present in two different complexes: mTORC1 and mTORC2, where it is associated with raptor and 
rictor, respectively. The mTORC1 complex controls protein synthesis, the importation of nutrients and 
autophagy. Inhibition of mTORC1 by rapamycin activates autophagy in all eukaryotic cells. The 
downstream targets of mTORC1 that regulate autophagy in mammalian cells are ULK1 and ULK2 [24]. 
Upstream, mTORC1 is itself inhibited by the heterodimer TSC1/TSC2 (TSC: tuberous sclerosis 
complex). TSC2 is a GTPase-activating protease acting on Rheb, which in its inactive GDP-form 
disassembles from mTORC1, resulting in its inactivation [25]. The mTORC1 complex integrates 
signals from multiple upstream signaling pathways. Growth factor signaling occurs via class I PI3K, 
and Akt/PKB (serine/threonine protein kinase B). Phosphorylation of TSC2 by Akt/PKB inactivates 
the TSC1/TSC2 complex, which in turn activates mTORC1. The mTORC1 complex is also activated 
by high amino acid levels via the stimulation of the heterodimer of Ras-related small GTPases (RAG). 
In contrast, activation of the energy sensor AMPK by an increase in the AMP/ATP ratio inactivates 
mTORC1 by activating TSC2. The second complex of mTOR, mTORC2, has been reported to regulate 
autophagy via the transcription factor FoxO, in the context of muscle atrophy [26,27]. 
The Beclin 1:hVps34 complex is also modulated by the recruitment of positive and negative 
regulators, by post-translational modifications of Beclin 1 [28], and by microRNA as recently   
reported [29]. In the last few years, we have seen a huge increase in the number of Beclin 1 
interaction-partners identified. Anti-apoptotic factors of the Bcl-2 protein family (Bcl-2, Bcl-xl) are the 
most abundantly documented repressors of Beclin 1. Under normal conditions, Bcl-2 interacts with 
Beclin 1, thus inhibiting autophagy [30]. In response to amino acid deprivation or ceramide treatment, 
the phosphorylation of Bcl-2 by JNK1 leads to reduced interaction between Bcl-2 and Beclin 1, which 
in turn triggers autophagy [31,32]. Viruses 2010, 2                                       
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Similarly, several factors such as DAP kinase, TRIF or MyD88 (myeloid differentiation factor 88), 
and BNIP3, which are activated by death signals, pathogens and hypoxia, respectively, enhance 
autophagy by reducing/disrupting the Beclin 1/Bcl-2 interaction [28,33,34]. MyD88 and TRIF are 
adaptor proteins recruited by activated toll-like receptors (TLRs) [34], and they are involved in the 
stimulation of autophagy induced by pathogens via TLRs [35]. Several viral proteins, such as ICP34.5 
(HSV-1) or vBcl-2 (HHV-8), have been shown to interact with Beclin 1, leading to the inhibition of 
autophagy, and will be discussed later in this review [36]. 
Autophagy is also upregulated by the stress-induced eIF2 kinase signaling pathway [37,38]. 
However, the way the eIF2 kinase signaling impacts on the autophagic machinery is still unknown. 
The eIF2 kinases are evolutionarily-conserved serine/threonine kinases that inhibit translation by 
phosphorylating and inhibiting the eukaryotic initiation factor 2 alpha (eIF2). In mammalian cells, 
four eIF2kinases, GCN2, PKR, PERK and HR1, activated by amino acid starvation, viral infection, 
ER stress and heme deprivation, respectively, are described [37]. It has been proposed that 
phosphorylation of eIF2 by GCN2 may trigger autophagy in yeast and in fibroblasts [38]. Double-
stranded RNA-activated protein kinase (PKR) is inducible by interferon (IFN), and can be activated by 
double-stranded RNA, a common intermediate in the replication of many viruses. PKR is a key player 
in the antiviral action of interferon, and many viruses express proteins that antagonize the PKR 
signaling pathway [39]. Activation of the PKR kinase has been shown to be involved in autophagy 
induction in murine fibroblasts infected with an HSV-1 mutant virus [38].  
Recent data suggest that activation of eIF2 kinase by PERK after the expression of misfolded 
polyglutamine 72 repeat (polyQ72) induces autophagy and upregulates Atg12 mRNA [40]. Other studies 
have also reported that autophagy is induced by ER stress but, in contrast, that autophagy is activated 
via the IRE-1-JNK pathway and not via PERK in neuroblastoma cells treated with ER stressors [41]. The 
signaling pathways that link ER stress to autophagy might therefore be cell-dependent.  
1.3. Autophagy and Viruses 
Several recent reviews address the interplay between viruses and autophagy [39,42,43]. Autophagy 
protects host cells against viral attack by degrading the viruses in autolysosomes, or by activating the 
innate immunity of the cells by loading viral components onto endosomal sensors such as TLRs [35,44]. 
It has been suggested that autophagy may have a deleterious effect on viral pathogenesis in the case of 
the neurotropic Sindbis virus [45], and the role of autophagy has been clearly demonstrated to limit the 
replication of the tobacco mosaic virus [46]. Autophagy is also involved in the adaptative immune 
responses to microorganisms infection, for example by providing viral endogenous antigens for 
loading onto major histocompatibility complex (MHC) class I and class II in order to activate the 
adaptive immunity [47–49]. Some viruses have been shown to have developed diverse tactics to 
antagonize the host cell’s autophagic defense. Most of them belong to the Herpesviridae family, and 
the mechanisms they employ are discussed later in this article. Inhibition of autophagy has also been 
reported in HIV-infected CD4 T-lymphocytes [50]. Moreover, HIV has been shown to inhibit the 
fusion of autophagosomes with lysosomes in macrophages through interaction of the viral protein Nef 
with Beclin 1, leading to an accumulation of autophagosomes in the cytoplasm [50,51]. Viruses 2010, 2                                       
 
 
319
In some situations autophagy is also able to act as a pro-viral pathway that helps viruses to replicate 
or exit from cells [52]. For example, stimulation of autophagy has been reported to increase the yields 
of poliovirus, hepatitis C virus (HCV), Dengue virus and Coxsackie B virus [53–55]. It has also been 
suggested that autophagy may help poliovirus particles to exit from the cell during the late stages of 
infection [56]. HCV induces the accumulation of autophagosomes in infected cells, but inhibits their 
fusion with lysosomes [54], and seems to require autophagy at an early stage of the infection [55]. 
2. Autophagy is Modulated by Herpesviruses 
Autophagy is activated by Herpesviruses, and thus may play an important role in the antiviral cell 
defense either by clearing intracellular viruses (xenophagy) or by activating antigen presentation [42]. 
It is not therefore surprising that Herpesviruses have evolved mechanisms to antagonize autophagy. 
Some of them have developed proteins that inhibit PKR-eIF2 signaling, which triggers autophagy as 
part of a global antiviral IFN response, but an increasing number of Herpes viral proteins have been 
reported to target the autophagic machinery more specifically. However, a few cases have also been 
documented, in which Herpesviruses are not able to inhibit autophagy [47,57]. 
2.1. Alphaherpesvirinae 
2.1.1. Herpes Simplex Virus Type 1 (HSV-1) 
The regulation of autophagy by HSV-1 infection was first reported in 2002 [38], and has now been 
well documented, using both in vitro and in vivo approaches. HSV-1 is known to be able to antagonize 
the host autophagy response in fibroblasts [38], in primary murine neurons [44], and in   
macrophages [47]. However, during the late phase of macrophage infection, HSV-1 stimulates 
autophagosome formation. Taken together these data suggest that the modulation of autophagy by 
HSV-1 could be either cell-type dependent and/or time dependent. In fibroblasts and neurons, HSV-1 
counteracts the induction of autophagy via Infected Cell Protein 34.5 (ICP34.5), which is encoded by 
the neurovirulence gene gamma134.5, and which acts by two separate mechanisms: binding to Beclin 1, 
and antagonizing autophagy-stimulating PKR signaling [36]. The HSV-1 protein ICP34.5 has been 
shown to block the translational repression of PKR by recruiting a cellular phosphatase, PP1, which 
leads to PKR-mediated eIF-2α dephosphorylation despite the presence of activated PKR [58]. A 
deletion mutant HSV-1 virus, which lacks the 134.5 gene, strongly activates PKR signaling, and 
causes the premature shutoff of protein synthesis in various different cell types, and is neuroattenuated 
in mice [59]. The first report of an impact of ICP34.5 on autophagy was that of Tallóczy et al., who 
discovered that the PKR-eIF-2α pathway regulates positively autophagy [38]. Indeed, an ICP34.5 
deletion mutant virus has been shown to promote autophagy in murine embryonic fibroblasts (MEFs), 
unlike the wild type virus, but it no longer triggers autophagy in the PKR-/- and Ser-51 
nonphosphorylatable mutant eIF2 MEFs [38]. Taken together, these data show that HSV-1 infection 
activates PKR and stimulates autophagy, but that the expression of ICP34.5 allows the virus to block 
PKR signaling and so to antagonize the induction of autophagy (Figure 1). Interestingly, the 
autophagic protein Beclin 1, which was initially identified as a Bcl-2 interacting protein (35), has also 
been reported to interact with ICP34.5 in a yeast two-hybrid screen using ICP34.5 as bait (B. Roizman, Viruses 2010, 2                                       
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personal communication). Following on from this, Levine and colleagues reported recently that 
ICP34.5 binds directly to human Beclin 1, and inhibits its autophagy function (Figure 1) [36]. In the 
absence of HSV-1 infection, the expression of ICP34.5 is sufficient in itself to block starvation-
induced autophagy in both yeast and mammalian cells. The ICP34.5 binding-domain of Beclin 1 has 
not yet been clearly identified, but is known to differ from the Bcl-2-binding domain. In contrast, the 
Beclin-1 binding-domain of ICP34.5 maps to amino-acids 68-87, and is distinct from the   
GADD34-related region involved in the dephosphorylation of eIF2. 
2.1.1.1. Impact of Autophagy on HSV-1 Viral Replication  
It is tempting to speculate that autophagy is inimical for virus life, since HSV-1 has developed 
various strategies to block this cellular process. However, the impact of autophagy on HSV-1 
replication is still controversial. Talloczy et al. reported that the growth of an ICP34.5 deletion mutant 
virus was defective in normal cells, whereas in PKR-/- MEFs, replication of this mutant virus could be 
restored [44]. In PKR-/- cells, autophagy is functional but cannot be induced by viral infection. This 
had already been reported previously, but had been attributed to the role of ICP34.5 in inhibiting PKR-
dependent host cell shutoff [60]. However, in autophagy-deficient Atg5-/- MEFs, deficient growth of a 
ICP34.5 deletion mutant virus was not abolished [61]. These latest observations tend to suggest that 
autophagy does not in fact have any impact on the viral replication cycle in cell cultures, and so cannot 
be responsible for the growth defect of the ICP34.5 deletion mutant virus.  
However,  in vivo investigations of the role of ICP34.5 have indicated that autophagy might 
contribute to the pathogenesis of HSV-1 [36]. ICP34.5 was initially identified in Roizman’s 
laboratories as the neurovirulence factor of HSV-1, [59]. It has been proposed that ICP34.5 contributes 
to neurovirulence by blocking the host cell shutoff mediated by PKR eIF2 signaling [62]. Supporting 
this surmise, an ICP34.5 deletion mutant virus displayed wild-type virulence in mice lacking PKR [63]. 
However, a Beclin 1-binding-deficient ICP34.5 mutant virus is highly neuroattenuated in mice [36]. 
These findings show that the ICP34.5/Beclin 1 interaction, and consequently the inhibition of 
autophagy by ICP34.5 might be another factor that contributes to viral neurovirulence, independently 
of the role of ICP34.5 in antagonizing host cell shutoff. Furthermore, the neurovirulence of Beclin 1-
binding-deficient ICP34.5 HSV-1 was fully restored in PKR-/- mice, suggesting that PKR is connected 
to Beclin 1 in the regulation of autophagy. Further studies will be necessary to elucidate the complex 
relationships between neurovirulence, ICP34.5 and autophagy control.  
Interestingly, the HSV-1 Us11 gene is also dedicated to regulating the PKR eIF2signaling 
pathway [64,65]. The Us11 protein is a double-stranded RNA binding protein, expressed with late 
kinetics, which can antagonize PKR either by a direct interaction or by interacting with PACT, an 
activator of PKR [64,66]. Immediate early kinetic expression of the Us11 protein in an ICP34.5 
deletion mutant virus restores the ability of the virus to reverse eIF2 phosphorylation and the shutoff 
of protein synthesis [67]. This mutant virus, which does not express ICP34.5, is able to inhibit virus-
induced and PKR-mediated autophagy (our unpublished results). Viruses 2010, 2                                       
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2.1.1.2. Antiviral Mechanisms of Autophagy 
The way autophagy contributes to the antiviral innate immune response in the context of HSV-1 
infections is still puzzling. Talloczy et al. reported that xenophagy plays a role in degrading HSV-1 
virions, based on the presence of virions visualized by electron microscopy inside autophagosomes, 
and on the accelerated degradation rate of viral proteins after infection with an ICP34.5 deletion 
mutant [44]. However, these ultrastructural studies were done at a late stage in the infection, and the 
entrapped virions corresponded to de novo synthesized viral particles. Degradation of both structural 
and non structural viral proteins is enhanced in the context of unrestrained autophagy, but it is not 
necessarily correlated with the degradation of entire HSV-1 particles [44]. The ability of xenophagy to 
capture and eliminate new incoming HSV-1 virions therefore remains to be demonstrated.  
Autophagy might rather play a key role in the adaptive immune response by generating peptides 
from trapped virions for presentation by the MHC class I and II molecules [47,68]. Indeed, a recent 
paper has reported that the neurovirulence of the Beclin 1-binding-deficient ICP34.5 mutant virus was 
completely restored in mice lacking functional T and B cells, clearly connecting autophagy to the 
control of adaptative immune response [68]. English et al. have also reported that autophagy is 
involved in the presentation of the viral glycoprotein gB to CD8+ T cells by MHC class I, in 
collaboration with the canonical ER-dependent pathway [47]. These authors have also shown that the 
infection of macrophages by HSV-1 leads to an ICP34.5 dependent inhibition of autophagy in the early 
infection phase, followed by stimulation of the autophagic pathway in the late phase. Interestingly, 
these late phase autophagosomes consisted of both classical autophagosomes and four-layered 
membrane structures emerging from both the inner and outer nuclear membranes. Their findings 
showed that the processing of glycoprotein gB for MHC class I presentation in HSV-1 infected 
macrophages occurs in two phases: first via the classical pathway involving proteasome-mediated 
degradation during the early infection phase, and then via this newly-characterized nuclear membrane-
derived autophagy during the late infection phase (Figure 2) [69]. 
2.1.2. Bovine Herpes Simplex Virus Type 1 (BHV-1) 
Recent findings suggest that BHV-1 may have developed a strategy to evade autophagy, as has its 
cousin, HSV-1. Kidney cells infected by a mutant BHV-1 virus lacking bovine Infected Cell Protein 0 
(bICP0) displayed more autophagosomes than cells infected with the wild-type virus, indicating that 
bICP0 might antagonize autophagy [70]. This bovine homolog of ICP0 has also been reported to 
protect kidney cells against UV-induced apoptosis, since a bICP0 null mutant virus was unable to 
inhibit UV-induced apoptosis [70]. 
2.1.3. Varicella-zoster Virus (VZV) 
A recent paper reports that VZV stimulates autophagy during the late stages of infection in both 
fibroblasts and melanoma cells [57]. Interestingly this stimulation of autophagy has also been 
corroborated by in vivo data, since LC3 was expressed abundantly in infected cells taken from biopsies 
of zoster vesicles. Therefore, in contrast to HSV-1, VZV appears to be unable to evade the host’s 
autophagy machinery. Moreover, no ortholog of the HSV-1 134.5 gene, or viral Bcl-2 homolog, such Viruses 2010, 2                                       
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as those known to be present in gammaherpesviruses, could be detected in the VZV genome. Although 
the physiological relevance of VZV-induced autophagy is still unknown, Takahashi et al. suggest that 
autophagy could be responsible for the low yields of cell-free VZV [57]. VZV is in fact known to 
remain highly cell-associated in cell cultures, and enveloped virions accumulate in acidic cytoplasmic 
vacuoles other than lysosomes, which means that autophagy might limit viral production by trapping 
viral particles in the autophagosomal pathway.  
Figure 2. Contribution of autophagy to adaptative immunity against Herpesviruses. 
 
There are two examples of autophagy-dependent MHC presentation of herpesvirus proteins [47,48]. 
The EBV protein EBNA1 is presented onto MHC class II molecules via autophagy (A). In HSV-1 
infected macrophages, the glycoprotein gB is processed both through the classical MHC class I 
presentation pathway involving the proteasome (B) and through a vacuolar pathway involving 
autophagy and partially lysosomal digestion. The glycoprotein gB was detected in classical 
autophagosomes (C) as well as in newly discovered four-layered membrane autophagosomes 
derived from the nucleus (D). 
2.2. Betaherpesvirinae 
2.2.1. Human Cytomegalovirus (HCMV) 
HCMV is a widespread opportunistic pathogen that causes severe
 diseases and death in newborn 
infants and immunocompromised individuals. By monitoring autophagosome formation and 
autophagic flux, a recent study has reported that HCMV is able to counteract the autophagic antiviral 
response in human embryonic fibroblasts after 24 hours of infection, dependently of viral protein Viruses 2010, 2                                       
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synthesis [71]. Despite a dramatic decrease in the number of autophagosomes after HCMV infection, 
the expression and conjugation of LC3 are both increased, suggesting that HCMV achieves the fine 
modulation of autophagy by inhibiting some specific steps in the autophagic pathway and enhancing 
others [71]. The precise mechanisms involved in the inhibition of autophagy by HCMV are still unclear. 
However, it has been reported that HCMV activates autophagy-inhibiting mTOR signaling [71,72], and 
inhibits autophagy-stimulating PKR signaling via the interaction between two related viral proteins, 
TRS1 and IRS1, with PKR and dsRNA [73]. These signaling pathways could therefore be involved in 
the inhibition of autophagy. The fact that HCMV-infected cells are resistant to autophagy induced by 
rapamycin, an mTOR inhibitor, and by lithium chloride, which acts independently of mTOR, also 
suggests that HCMV targets several regulatory pathways [71]. In view of the interplay known to exist 
between apoptosis and autophagy [74,75], apoptosis-inhibitory HCMV gene products, such as vMIA, 
VICA or UL38, could also be involved in the control of autophagy by HCMV [76]. Notably, the 
product of the early gene UL38 might prevent autophagy via mTOR signaling, since pUL38 has been 
shown to bind TSC2 and to antagonize the ability of the TSC1/TSC2 complex to downregulate mTOR 
complex 1 [77]. The inhibition of autophagy by HCMV appears to be very complex since it involves 
several regulation pathways and is time dependent. Indeed, autophagy is induced during the first hours 
of infection, independently of the expression of viral proteins, because this stimulation is observed 
even in the context of cells infected with UV-inactivated HCMV (our unpublished data). 
2.2.2. Human Herpesvirus (HHV-6) 
HHV-6, which belongs to the Roseolovirus genus of the –Herpesvirus subfamily, is related to 
HHV-7 and, to a lesser extent, to HCMV. The impact of HHV-6-infection on autophagy is still 
unexplored. It is noteworthy that HHV-6 uses human CD46 as a cellular receptor during fusion with 
and entry into target cells [78]. CD46, which is well known to act as a receptor for several pathogens, 
has been reported very recently to induce autophagy via a pathway involving the Beclin 1 complex 
after measles virus infection [79]. These findings suggest that HHV-6 infection could also modify the 
level of autophagy. 
2.3. Gammaherpesvirinae 
2.3.1. Epstein-Barr Virus (EBV) 
EBV infects the oral epithelium, where it undergoes lytic replication, and resting B lymphocytes, 
where it establishes long-term latency. Up to nine EBV proteins are expressed during latency: six 
EBV-encoded nuclear antigens (EBNA-1-6), and three latent membrane proteins (LMP-1, -2A, -2B). 
Expression of these latent proteins contributes to EBV properties for proliferation and/or 
transformation of host cells, predisposing them to numerous malignancies. Nothing is yet known about 
the interplay between autophagy and the lytic cycle of EBV, but at least two latent antigens, EBNA 1 
and LMP1, are known to activate or to interfere with the autophagic machinery [48,80]. 
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2.3.1.1. EBNA1 Is Loaded onto MHC Class II after Macroautophagy 
EBNA1 is essential for latency, since it enables the replication and persistence of EBV genomes in 
latently infected cells, and activates the expression of other latency genes. Being an endogenous 
antigen, EBNA1 would be expected to be loaded onto MHC class I after proteasomal processing. 
However, in fact EBNA1 inhibits its own proteasomal-mediated turnover, and consequently its 
presentation on MHC class I [81]. In contrast, EBNA1 elicits a CD4+ T cell immune response after 
intracellular MHC class II processing. Paludan et al. have demonstrated that autophagy contributes to 
MHC class II-EBNA1 presentation in EBV-transformed lymphoblastoid cells [48] by delivering this 
EBV antigen to the lysosomal compartment, where the processing occurs. Inhibition of lysosomal 
acidification induces an accumulation of EBNA1 in autophagosomes, as revealed by ultrastructural 
analysis of EBNA1-transfected Hodgkin's lymphoma cells, while suppression of autophagy by 3-
methyladenine or by small interfering RNA restrained the intracellular processing of EBNA1, and 
consequently its MHC class II presentation. In contrast, the MHC class II presentation of two other 
EBV latent proteins, EBNA2 and EBNA3C, does not involve autophagy, but depends on intercellular 
antigen transfer [82]. Endogenous MHC class II processing after autophagy has also been reported for 
other proteins, complement C5, Mucin 1 oncoprotein and a bacterial antigen neomycin 
phosphotransferase [83]. However to date, EBNA1 is the only viral antigen known to be presented on 
MHC class II via the autophagic pathway.  
2.3.1.2. Latency-associated LMP1 Induces Autophagy  
LMP1 is a viral protein of EBV expressed in latency, and in many EBV-associated tumors, 
including non-Hodgkin lymphoma. This oncogene has been shown to drive proliferation of EBV-
infected B cells via a signaling pathway similar to that of CD40 [84]. LMP1 is expressed at a wide 
range of levels in B-cells originating from the same clone, and Lee and Sugden showed that this 
variation controls the induction of different signaling pathways: intermediate levels of LMP1 
expression are required for B-cell proliferation to occur, whereas higher levels induce the unfolded 
protein response (UPR), by activating the PKR-like endoplasmic reticulum-related kinase (PERK) [85]. 
UPR activation is thought, in turn, to drive the synthesis of LMP1 [85]. The same authors reported that 
the expression of LMP1 induced autophagy in both EBV-infected B cells and EBV-negative cells 
expressing exogenous LMP1 [80]. The stimulation of autophagy was also correlated with the level of 
LMP1 expression: cells expressing low levels of LMP1 displayed autophagosomes, while those 
expressing higher levels displayed autolysosomes. The transmembrane domains 3–6 of LMP1 were 
shown to be responsible both for inducing autophagy and activating PERK. The UPR, which is 
induced by the accumulation of unfolded proteins in the ER, includes the activation of PERK and 
transcription factor 6 (ATF6), and the induction of inositol requiring kinase 1 (IRE-1). Interestingly, 
several studies have reported the induction of autophagy by ER stress, notably after activation of 
eIF2 by PERK, thus linking autophagy to the UPR [37,40]. The signaling pathway leading from 
LMP1 to autophagy is still unclear, but might involve PERK activation by the transmembrane domain 
of LMP1. Further investigations are necessary to clarify the exact roles of autophagy in EBV-infected 
cells. Lee and Sugden have proposed that autophagy might regulate the turnover of LMP1 by 
delivering it to lysosomes [80]. Indeed, inhibiting autophagy promoted the accumulation of LMP1, and Viruses 2010, 2                                       
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induced a slight decrease in cell proliferation. Therefore, the activation of autophagy and UPR by EBV 
both seem to be responsible for the variable LMP1 levels. 
2.3.2. Viral Bcl-2 Homologs of Herpesviruses Are both Antiapoptotic and Antiautophagic 
Apoptosis is used by host cells as part of their antiviral response, and impairs virus production by 
triggering premature cell death. As a consequence, many viruses have developed strategies to 
counteract virus-induced apoptosis. Gammaherpesvirinae, for example, encode viral homologs of the 
cellular antiapoptotic proteins Bcl-2 and FLIP (FLICE-like inhibitor protein) to prevent host cell death. 
However, recent findings have demonstrated that these proteins also suppress autophagy [30,86–88]. 
Although autophagy is a recognized cell survival mechanism, there is also evidence of an 
interconnection between autophagy and apoptosis [75,89] and, for example,  several mediators of 
apoptosis have been shown to control autophagy. Therefore, it is not unexpected to find that some 
antiapoptotic proteins also repress autophagy. Viral Bcl-2 homologs, vBcl-2, M11 and BHRF1, have 
been reported in HHV-8, mouse Herpesvirus strain 68 (HV-68) and EBV respectively [90–92]. Several 
results indicate that these proteins are essential for γ-Herpesvirus pathogenesis, but so far M11 is the only 
γ-herpesvirus Bcl-2 homolog that has definitely been shown to play a role during infection in vivo [93]. 
Pattingre et al. were the first to demonstrate that cellular and HHV-8 Bcl-2s inhibit autophagy through 
interacting with the BH3 domain of Beclin 1 [30]. Subsequently, the Bcl-2 homolog of γHV68 was 
also reported to inhibit autophagy by interaction with Beclin 1 [86,87]. The antiautophagic properties 
of the EBV Bcl-2 homolog, BHFR1, have not yet been investigated. The autophagy-inhibitory-
complex formed by cellular Bcl-2 and Beclin-1 can be modulated by nutrient conditions, whereas viral 
Bcl-2 forms a stable association with Beclin-1, which results in a constant repression of autophagy [31]. 
Starvation leads to dissociation of the cellular Bcl-2-Beclin 1 complex as a result of the 
phosphorylation of cBcl-2 by activated JNK1, and consequently an induction of autophagy [31]. JNK1 
phosphorylates cellular Bcl-2 at three sites present in the nonstructured loop, which are absent in the 
viral Bcl-2 proteins. Moreover, M11 has been reported to bind to Beclin 1 more strongly than cellular 
or HHV-8 Bcl-2 [87]. The enhanced anti-autophagic activity of viral Bcl-2 suggests that autophagy 
plays an important role as an antiviral cellular defense mechanism. It has also been proposed that viral 
Bcl-2 proteins may inhibit Beclin 1-mediated tumor suppression, and so the inhibition of autophagy 
might promote oncogenic events [89]. 
The regulatory protein FLIP, which contains death effector domains (DED) such as the adaptator 
protein FADD and the procaspases 8 and 10, regulates apoptosis from death receptors [94]. Cellular 
FLIP (cFLIP), and viral FLIP (vFLIP) of HHV-8 and Herpesvirus Saimiri, have recently been shown 
to inhibit autophagy induced by starvation or rapamycin, similarly to Bcl-2 [88]. FLIP interacts with 
the E2-like enzyme Atg3 and represses autophagy by preventing the binding of Atg3 to LC3. 
Consequently, FLIP prevents the conjugation of LC3 which is essential for autophagic vesicle 
expansion. Interestingly, rapamycin, a known inducer of autophagy, displays tumor suppressor activity 
against HHV-8 induced Kaposi’s sarcoma and primary effusion lymphoma. FLIP expression prevented 
autophagic cell death induced by rapamycin, hinting that autophagy inhibition may be relevant for in 
vivo HHV-8 pathogenesis [88]. Thus, Herpesviruses, via interaction of vBcl-2 and vFLIP with 
Beclin 1 and Atg3 respectively, impact two stages of autophagosome formation [88]. The fact that the Viruses 2010, 2                                       
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herpesviruses have evolved proteins that inhibit autophagy at various different steps highlights the 
importance of controlling this mechanism. The significance of this inhibition is not yet known for the 
pathogenesis of the Gammaherpesvirinae subfamily, but might be linked to the oncogenic potential of 
these viruses, and autophagy and apoptosis might execute protective functions in concert. 
3. Conclusions 
All three subfamilies of Herpesviridae have evolved distinct strategies to block the induction of 
autophagy in infected cells (table 1). Evasion of host autophagy occurs by direct inhibition of the 
autophagic machinery via interaction with Beclin 1 (HSV-1 ICP34.5 or the viral Bcl-2 homologs of 
herpesvirus), with Atg3 (herpesvirus FLIP homolog) or via regulation pathways including 
activation of the inhibitory mTOR pathway (HCMV) and inhibition of the PKR/eIF2 pathway 
(HSV-1). The same host autophagy protein, Beclin 1, is targeted by different herpesviruses and via 
diverse strategies, which is not surprising given the central role of Beclin 1 in the regulation of 
autophagy. More remarkably, the same viral protein (HSV-1 ICP34.5) prevents the induction of 
autophagy by two different routes. The resourcefulness shown in strategies that target autophagy 
underscores the importance for Herpesviruses of blocking this cellular mechanism.  
In most cases, Herpesviruses seem to be able to overcome cellular autophagy, but few examples 
have also been documented of Herpesviruses that are not able to control autophagy [47,57]. VZV 
actually stimulates autophagy during late stages of infection, but the fact that VZV does not encode an 
anti-autophagic protein could account for this [57]. Autophagy induction has also been reported in 
macrophages infected with HSV-1, whereas this same virus is able to block autophagy in neurons and 
in fibroblasts [36,47]. 
Autophagy has been reported to produce some antiviral effects against Herpesviruses, including 
xenophagy, i.e., the direct degradation of viruses in autolysosomes [44], and viral antigen presentation 
on MHC class I and II [47,48], but other mechanisms could also be involved. While the deleterious 
effect of autophagy on in vitro viral growth is not obvious [61], some studies do seem to indicate that 
autophagy helps to restrict viral pathogenesis, such as the neurovirulence of HSV-1 [36] or the virus-
induced oncogenesis of certain gamma Herpesviruses [89]. Autophagy has recently also been 
demonstrated to impede in vivo viral growth by activating the adaptive immunity [68]. 
Herpesviruses are major pathogens which are able to persist throughout the lifetime of the infected 
host by establishing latent infections. No currently available drugs eradicate these viruses, since anti-
herpes drugs target viral genome replication. It is crucial to find out how autophagy acts as an antiviral 
defense mechanism against herpesviruses, because this mechanism could provide a target for a new 
therapeutic approach. Interestingly, rapamycin, which is known to induce autophagy, has been reported 
to decrease the incidence and gravity of HCMV infections after organ transplantation [95,96]. Similarly, 
rapamycin treatment seems also detrimental to the pathogenesis of gamma Herpesviruses, such as 
EBV and HHV-8. However, because rapamycin also targets pathways other than autophagy, it is 
difficult to isolate the role of autophagy stimulation in its therapeutic action. New agents that 
specifically target autophagy will have to be developed to test this potential new antiviral approach. 
Future studies will also have to find out more precisely when and how autophagy prevents   
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Table 1. Relationships between Herpesvirus and autophagy. 
Herpesvirus  Viral evasion of autophagy  Autophagy promotion 
Host-virus interactions and 
host antiviral defense 
Viral proteins/mechanisms  Ref. 
Alphaherpesvirinae 
Herpes simplex 
virus type 1  
(HSV-1) 
 
HSV-1 infection inhibits  
autophagy in neurons and in 
fibroblasts 
 
 
 
 
 
 
 
HSV-1 infection induces 
autophagy in  
macrophages 
 
Viral control of autophagy is 
involved in neurovirulence 
 
 
Autophagy contributes to 
MHC class I presentation of 
gB to CD8+ cells 
 
ICP34.5 blocks autophagy by 
inhibiting PKR signaling and by 
direct interaction with Beclin 1 
 
gB  
 
 
[38] 
[36] 
[61] 
 
 
[47] 
Bovine herpesvirus 
type 1 (BHV-1) 
BHV-1 WT may inhibit 
autophagy whereas the bICP0 
null mutant may induce 
autophagy in MDBK cells 
    bICP0 may block autophagy  [70] 
Varicella-zoster 
Virus (VZV) 
 
VZV stimulates 
autophagy in fibroblasts 
 and in vivo in human 
zoster vesicles  
 Unknown  [57] 
Betaherpesvirinae 
Human 
cytomegalovirus 
(HCMV) 
 
HCMV inhibits autophagy in 
human fibroblasts 
  
 
May activate mTOR pathway? 
 
 
[71] 
Gammaherpesvirinae 
Epstein-Barr virus 
(EBV) 
 
 
A latency-associated 
protein (LMP1) induces 
autophagy 
 
 
 
 
Autophagy contributes to 
MHC class II presentation of 
EBNA1 to CD4+ cells 
 
LMP1 
Proposed role in regulating its 
own expression level 
 
Latency associated  
protein EBNA1 
 
[80] 
 
 
 
[48] 
Human 
Herpesvirus 8 
(HHV8), 
murine ￿-HV68 
HHV8 may inhibit autophagy 
 
Unknown 
 
Viral homologs of Bcl-2 
(vBcl-2, M11) inhibit  
autophagy by its  
interaction with Beclin 1 
 
Viral homologs of FLIP (vFLIP) 
inhibit autophagy by interaction 
with Atg3 
 
[30] 
[86] 
[89] 
 
 
 
[88] 
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